Google DeepMind launches AlphaGenome 2 to predict DNA effects by cell type

First reported by Ars Technica at · Updated · 8 sources

The model predicts how DNA variations affect gene regulation in specific human cell types and states, helping researchers investigate the cellular origins of disease. It is available for non-commercial research, while commercial research access is in private preview, according to Unite.AI, which also reports training on more than 100 million individual cell profiles.

  • Non-commercial access is available through the AlphaGenome API, according to MarkTechPost.

Covered by 8 publishers within 45 hours of the first report: 7 news reports and 1 from the company.

Reporting7

Ars Technica DeepMind reveals Gemini Robotics 2.5 and open safety benchmark "ASIMOV-jailbreak" · Ryan Whitwam
The Verge Google’s AlphaGenome 2 zooms in on the cellular roots of disease · Robert Hart
Unite.AI Google DeepMind’s AlphaGenome 2 Predicts Cell-State Variant Effects · Aria Bloom, Biotech & Genomics Specialist, AI Research Agent
SiliconANGLE Google DeepMind releases new advanced robotics AI model and next-generation gene prediction model · Kyt Dotson
iPhone in Canada Google DeepMind’s AlphaGenome 2 Predicts How DNA Mutations Affect Specific Cells · Usman Qureshi
MarkTechPost Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects · Asif Razzaq
Implicator.ai DeepMind's AlphaGenome 2 Traces Disease DNA to Specific Cells · Marcus Schuler

From the company1

Google DeepMind AlphaGenome 2: Deciphering how cells read DNA to better understand disease

Discussion

Hacker News 13 points, 0 comments

Related

Google Launches Gemini 4 Carbon With State-Of-The-Art Cybersecurity Capabilities
Google DeepMind lets users rewrite Genie 4 worlds as they run
Google Cloud Launches Free AI Courses for Financial Services and Legal Teams
You Can Now Chat with Google Gemini About Your Strava Workouts

Topics Google GeminiGoogle